To develop a highly safe measure to treat Alzheimer's disease using a secretase-inhibiting substance, there is provided a compound represented by the following general formula (I) or a salt thereof:
wherein A represents a phenyl group or the like, R
1
represents a chlorine atom, a bromine atom, or a nitro group or the like, R
2
, R
3
, R
4
, and R
5
each represent a hydrogen atom or the like, and L represents CH
2
—CH
2
or CH═CH.
COMPOUND, INK, INK CARTRIDGE AND INK JET RECORDING METHOD
申请人:CANON KABUSHIKI KAISHA
公开号:US20170247557A1
公开(公告)日:2017-08-31
A compound is represented by the following formula (1).
In the compound represented by Formula (1), at least one of R
1
to R
24
is a group particularly high electron withdrawing property, such as a sulfonic acid group and a carboxylic acid group or a group having the next highest electron withdrawing property to the sulfonic acid group and the carboxylic acid group, such as a halogen atom.
[EN] CRTH2 MODULATORS<br/>[FR] MODULATEURS DE CRTH2
申请人:IRONWOOD PHARMACEUTICALS INC
公开号:WO2010039982A1
公开(公告)日:2010-04-08
Modulators of CRTH2, particularly antagonists of CRTH2, that are useful for treating various disorders, including asthma and respiratory disorders are disclosed. The compounds fall within a genus described by formula I.
Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
申请人:——
公开号:US20030003049A1
公开(公告)日:2003-01-02
The present invention provides novel diagnostic compositions comprising a radiolabeled LTB4 binding agent and a radiolabeled perfusion imaging agent, diagnostic kits comprising such compositions, and methods of concurrent imaging in a mammal comprising administering a radiolabeled LTB4 binding agent and a radiolabeled perfusion imaging agent, and concurrently detecting the radiolabeled LTB4 binding agent bound at the LTB4 receptor and the radiolabeled perfusion imaging agent.
Radiopharmaceuticals for imaging infection and inflammation
申请人:——
公开号:US20030124053A1
公开(公告)日:2003-07-03
The present invention provides novel radiopharmaceuticals useful for the diagnosis of infection and inflammation, reagents and kits useful for preparing the radiopharmaceuticals, methods of imaging sites of infection and/or inflammation in a patient, and methods of diagnosing diseases associated with infection or inflammation in patients in need of such diagnosis. The radiopharmaceuticals bind in vivo to the leukotriene B4 (LTB4) receptor on the surface of leukocytes which accumulate at the site of infection and inflammation. The reagents provided by this invention are also useful for the treatment of diseases associated with infection and inflammation.